Imaging News

Clinical outcomes for patients with malignancies have improved in the past decade, in part due to the emergence of VEGF inhibitors.

In a new analysis from the ISCHEMIA trial of patients with stable ischemic heart disease, those with intermediate left main disease had worse prognosis than those with little or no left main stenosis, but an invasive strategy improved their angina-related quality of life.

Right ventricular longitudinal strain predicted higher mortality in patients with COVID-19, according to a study published in JACC: Cardiovascular Imaging.

Philips announced that it has received 510(k) clearance from the FDA to market its ultrasound solutions portfolio for the management of lung and cardiac complications associated with COVID-19.

Caption Health announced that the FDA issued an updated clearance for its artificial intelligence-guided image acquisition system for use with cardiac ultrasound, which has the potential to minimize caregiver contact with patients with known or suspected COVID-19.

In patients with embolic stroke of undetermined source, atrial fibrosis predicted recurrent stroke or new atrial fibrillation, according to data presented at the virtual Heart Rhythm Society Annual Scientific Sessions.

In patients with embolic stroke of undetermined source, atrial fibrosis predicted recurrent stroke or new atrial fibrillation, according to data presented at the virtual Heart Rhythm Society Annual Scientific Sessions.

In well-treated patients with atrial fibrillation, most of whom were on oral anticoagulation, more than 5% had a new brain infarct at 2 years, according to data presented at the virtual Heart Rhythm Society Annual Scientific Sessions.

Ambulatory telemetry monitors for patients with COVID-19 being treated with hydroxychloroquine and/or azithromycin provided real-time alerts to electrophysiologists and may improve their ability to monitor QTc changes and arrhythmias, reduce the need for serial ECGs and better allocate resources, researchers reported.

Once the COVID-19 pandemic starts to subside, gradual reintroduction and collaborative approaches are important to continue the care of patients with untreated CVD, according to guidance from 15 North American cardiology societies.